Enhancing Cognitive Restructuring with Concurrent Repetitive Transcranial Magnetic Stimulation for Transdiagnostic Psychopathology: A Proof of Concept Randomized Controlled Trial - Neacsiu, Andrada D.; Beynel, Lysianne; Powers, John P.; Szabo, Steven T.; Appelbaum, Lawrence G.; Lisanby, Sarah H.; LaBar, Kevin S. (medRxiv, 2021)
Background Emotional dysregulation constitutes a serious public health problem in need of novel transdiagnostic treatments. To this aim, we developed and tested a one-time intervention that integrates behavioral skills training with concurrent repetitive transcranial magnetic stimulation (rTMS).Methods Forty-seven adults who met criteria for at least one DSM-5 disorder and self-reported low use of cognitive restructuring (CR) were enrolled in a randomized, double-blind, placebo-controlled trial. Participants were taught CR and underwent active or sham rTMS applied at 10 Hz over the right or left dorsolateral prefrontal cortex (dlPFC) while practicing reframing and emotional distancing in response to autobiographical stressors.Results Those who received active as opposed to sham rTMS exhibited enhanced regulation (ds = 0.20 - 0.67) and reduced distress (ds = 0.32 - 0.35), as measured by self-report and psychophysiological indices during the intervention (higher high-frequency heart rate variability, lower regulation duration) and ambulatory self-report measures during the week following the intervention. All participants improved in their use of reappraisal (d = 2.25), psychopathology (d = 0.48) and emotional dysregulation (d = 0.81) and maintained their gains at the one month follow up. The procedures were acceptable and feasible with few side effects. A secondary analysis suggested that participants with stress disorders may respond particularly well to active right rTMS.Conclusion These findings show that engaging frontal circuits simultaneously with cognitive skills training and rTMS is clinically feasible, well-tolerated and shows promise as the next generation of treatments for transdiagnostic emotional dysregulation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02573246Funding StatementThis research and the completion of the manuscript were supported by a Brain and Behavior Young Investigator Award, a Duke internal award, and KL2 award granted to the first author and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 5KL2TR001115.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Duke University Health System Institutional Review Board Reviewed and approved the presented protocolAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo external datasets or supplemental materials are available at this time. Data sets and protocol materials can be obtained by e-mailing the first author (andrada.neacsiuatduke.edu)